We are live on ! Find out more
BEAM icon

Beam Therapeutics
BEAM

194 hedge funds and large institutions have $2.05B invested in Beam Therapeutics in 2023 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 78 increasing their positions, 47 reducing their positions, and 31 closing their positions.

New
Increased
Maintained
Reduced
Closed

134% more call options, than puts

Call options by funds: $16M | Put options by funds: $6.86M

66% more repeat investments, than reductions

Existing positions increased: 78 | Existing positions reduced: 47

11% more capital invested

Capital invested by funds: $1.85B → $2.05B (+$201M)

0.84% more ownership

Funds ownership: 83.39% → 84.24% (+0.84%)

6% less funds holding

Funds holding: 206 → 194 (-12)

35% less first-time investments, than exits

New positions opened: 20 | Existing positions closed: 31

67% less funds holding in top 10

Funds holding in top 10: 3 → 1 (-2)

Holders
194
Holders Change
-12
Holders Change %
-5.83%
% of All Funds
3.05%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.02%
New
20
Increased
78
Reduced
47
Closed
31
Calls
$16M
Puts
$6.86M
Net Calls
+$9.17M
Net Calls Change
+$16.1M

Top Buyers

1
BlackRock
BlackRock
New York
+$34.4M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$34.1M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$20.3M
4
NAMA
Nikko Asset Management Americas
New York
+$18.1M
5
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group
Japan
+$18.1M

Top Sellers

1
Capital Research Global Investors
Capital Research Global Investors
California
-$15.1M
2
Bank of America
Bank of America
North Carolina
-$6.47M
3
AIM
ARK Investment Management
Florida
-$6.19M
4
EC
EcoR1 Capital
California
-$6.08M
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$5.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
EHI
201
Eagle Health Investments
Connecticut
– -$885K -28,900 Closed
EGM
202
Engineers Gate Manager
New York
– -$828K -27,052 Closed
Capital Fund Management (CFM)
203
Capital Fund Management (CFM)
France
– -$825K -26,942 Closed
MOACM
204
Mutual of America Capital Management
New York
– -$812K -26,531 Closed
ACM
205
Aquatic Capital Management
Illinois
– -$713K -23,300 Closed
SG Americas Securities
206
SG Americas Securities
New York
– -$498K -16,277 Closed
PRC
207
Pearl River Capital
Michigan
– -$449K -14,676 Closed
Massachusetts Financial Services
208
Massachusetts Financial Services
Massachusetts
– -$319K -10,409 Closed
FRM
209
Fox Run Management
Connecticut
– -$301K -9,839 Closed
WG
210
Winton Group
United Kingdom
– -$271K -8,847 Closed
TI
211
Trexquant Investment
Connecticut
– -$250K -8,164 Closed
VF
212
Virtu Financial
New York
– -$239K -7,804 Closed
SO
213
STRS Ohio
Ohio
– -$156K -5,100 Closed
VFA
214
Values First Advisors
Tennessee
– -$43.4K -1,419 Closed
HIA
215
Harbor Investment Advisory
Maryland
– -$30.6K -1,000 Closed
BAM
216
Belpointe Asset Management
Nevada
– -$14.5K -475 Closed
DFCM
217
Dark Forest Capital Management
Puerto Rico
– -$9.4K -307 Closed
TWA
218
TCI Wealth Advisors
Arizona
– -$6.03K -197 Closed
ASN
219
Advisory Services Network
Georgia
– -$3.98K -130 Closed
CCM
220
Chilton Capital Management
Texas
– -$3.83K -125 Closed
BAM
221
Bellevue Asset Management
Washington
– -$2.3K -75 Closed
AAS
222
Ameritas Advisory Services
Nebraska
– -$1.53K -50 Closed
FDCDDQ
223
Federation des caisses Desjardins du Quebec
Quebec, Canada
– -$612 -20 Closed
EI
224
Ellevest Inc
New York
– -$490 -16 Closed
BTI
225
Blue Trust Inc
Georgia
– -$32 -1 -20%
5 6 7 8
9

BEAM Hedge Fund Activity: Q2 2023 in Review

194 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Beam Therapeutics (BEAM) for Q2 2023, worth a combined $2.05B — up 11% from $1.85B a quarter earlier.

Sellers outnumbered buyers: 31 funds closed out of BEAM and 20 opened new positions — a net loss of 11 holders — while 47 trimmed existing stakes and 78 added.

The largest buyer was BlackRock, adding an estimated $34.4M. The largest seller was Capital Research Global Investors, exiting entirely with an estimated $15.1M sold.

  • 194 institutional investors held Beam Therapeutics (BEAM) as of Q2 2023, down from 206 in Q1 2023.
  • Funds reported $2.05B of Beam Therapeutics stock for Q2 2023, up 11% quarter-over-quarter.
  • 20 funds opened new Beam Therapeutics positions in Q2 2023 and 31 closed out, a net change of -11 holders.
  • The largest Beam Therapeutics buyer in Q2 2023 was BlackRock, an estimated $34.4M added.
  • The largest Beam Therapeutics seller in Q2 2023 was Capital Research Global Investors, an estimated $15.1M sold.

Based on aggregated 13F filings for Q2 2023.